Towne CMV vaccine

BIOLOGICAL3 trials

Sponsors

Virginia Commonwealth University, University of California, San Francisco

Conditions

Cytomegalovirus InfectionCytomegalovirus Infections

Phase 1

Phase 1 Trial of CMV Towne Vaccine in Subjects Previously Received VCL CT02 Vaccine ID or IM

CompletedNCT00370006

University of California, San FranciscoCytomegalovirus Infection

Start: 2006-09-30End: 2007-08-31Target: 10Updated: 2007-01-11

Trial of pDNA CMV Vaccine (VCL-CT02) Followed by Towne CMV Vaccine (Towne) Challenge

CompletedNCT00373412

University of California, San FranciscoCytomegalovirus Infection

Start: 2006-10-31Target: 16Updated: 2008-05-08

Phase 2

Evaluation of the Safety and Immune Responses of the Towne Strain of CMV in Seronegative Women

TerminatedNCT00201448

Virginia Commonwealth UniversityCytomegalovirus Infections

Start: 2007-06-30End: 2009-10-31Updated: 2016-05-30